Trinucleotide repeat length and progression of illness in Huntington's disease

Journal of Medical Genetics

Volumn 31, Issue 11, 1994, Pages 872-874

  Kieburtz, Karl ^a   MacDonald, Marcy ^b   Shih, Charles ^a   Feigin, Andrew ^a   Steinberg, Kim ^a   Bordwell, Kathy ^a   Zimmerman, Carol ^a   Srinidhi, Jayalakshmi ^b   Sotack, Jenny ^a   Gusella, James ^b   Shoulson, Ira ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRINUCLEOTIDE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHROMOSOME 4; DISEASE COURSE; ENVIRONMENTAL FACTOR; FEMALE; GENE SEQUENCE; HUMAN; HUNTINGTON CHOREA; MALE; NEUROBIOLOGY; NUCLEOTIDE SEQUENCE; ONSET AGE; PRIORITY JOURNAL;

EID: 0028099274     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: 10.1136/jmg.31.11.872     Document Type: Article

References (15)

1. Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993;71:971-83.
2. Duyao M, Ambrose C, Myers R, et al. Trinucleotide repeat length instability and age of onset in Huntington's disease. Nantre 1993;4:387-92.
3. Snell RG, MacMillan JC, Cheadle JP, et al. Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease. Nature 1993;4:393-7.
4. Andrew SE, Goldberg YP, Kremer B, et al. The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease. Nature 1993;4:398-403.
5. Stine OC, Pleasant N, Franz ML, Abbott MH, Foistein SE, Ross CA. Correlation between the onset age of Huntington's disease and length of the trinucleotide repeat in IT-15. Hum Molec Genet 1993;2:1547-9.
6. Craufurd D, Dodge A. Mutation size and age at onset in Huntington's disease. J Med Genet 1993;30:1008-11.
7. Simpson SA, Davidson MJ, Barron LH. Huntington's disease in Grampian region: correlation of the CAG repeat number and the age of onset of the disease. J Med Genet 1993;30:1014-17.
8. MacMillan JC, Snell RG, Tyler A, et al. Molecular analysis and clinical correlations of the Huntington's disease mutation. Lancet 1993;342:954-8.
9. Roos RAC, Hermans J, Vegter-van der Vlis M, van Ommen GJB, Bruyn GW. Duration of illness in Huntington's disease is not related to age at onset. J Neurol Neurosurg Psychiatry 1993;56:98-100.
10. Young AB, Shoulson I, Penney JB, et al. Huntington's disease in Venezuela: neurologic features and functional decline. Neurology 1986;36:244-9.
11. Shoulson I, Kurlan R, Rubin AJ, et al. Assessment of functional capacity in neurodegenerative movement disorders: Huntington's disease as a prototype. In: Munsat TL, ed. Quantification of neurologic deficit. Boston: Butterworths, 1989:285-309.
12. Feigin A, Kieburtz K, Como P, et al. Predictors of disease progression in Huntington's disease (HD). Proceedings of the 15th International World Federation of Neurology Workshop on Huntington's Disease, 2 September 1993:A53.
13. Shoulson I, Odoroff C, Oakes D, et al. A controlled clinical trial of baclofen as protective therapy in early Huntington's disease. Ann Neurol 1989;25:252-9.
14. Warner JP, Barron JH, Brock DJH. A new polymerase chain reaction (PCR) assay for the trinucleotide repeat that is unstable and expanded on Huntington's disease chromosomes. Mol Cell Probes 1993;7:235-9.
15. Myers RH, Sax DS, Koroshetz WJ, et al. Factors associated with slow progression in Huntington's disease. Arch Neurol 1991;48:800-4.